Voorbeelden van het gebruik van Nnrtis in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Other NNRTIs.
Non-nucleoside reverse transcriptase inhibitors NNRTIs.
PIs or NNRTIs is unlikely.
NRTIs and NNRTIs.
Combining two NNRTIs has not been shown to be beneficial.
NRTIs and NNRTIs.
not with PIs or NNRTIs.
The best well-known NNRTIs are nevirapine and efavirenz.
Median previous NNRTIs.
PIs NNRTIs, such as nevirapine(Viramune) are the most common cause of medication skin rashes.
It is not recommended to co-administer Eviplera with other NNRTIs.
NNRTIs other than rilpivirine(efavirenz,
It is not recommended to co-administer INTELENCE with other NNRTIs.
NNRTIs are at the moment considered one of the essential ingredients of so-called anti-HIV cocktails.
The currently available data do not support sequential use of NNRTIs.
In vitro studies show that the metabolism of voriconazole may be inhibited by NNRTIs and voriconazole may inhibit the metabolism of NNRTIs. .
not with PIs or NNRTIs.
Other Non-Nucleoside Reverse Transcriptase Inhibitors(NNRTIs) e.g., delavirdine, nevirapine.
Non-nucleoside reverse transcriptase inhibitors NNRTIs.
Patients who discontinued treatment with other NNRTIs due to rash may be at higher risk of developing rash during treatment with efavirenz.
Non-nucleoside reverse transcriptase inhibitors(NNRTIs) Efavirenz 600 mg QD.
consisting of at least 2 antiretrovirals NRTIs with or without NNRTIs.
As with all other non-nucleoside reverse transcriptase inhibitors(NNRTIs), resistant virus emerges rapidly when efavirenz is administered as monotherapy.
particularly protease inhibitors and NNRTIs.
Since use of two NNRTIs proved not beneficial in terms of efficacy
Non-nucleoside Analogue Reverse Transcriptase Inhibitors(NNRTIs) Efavirenz 600 mg QD.
It belongs to a class of medications known as non-nucleoside reverse transcriptase inhibitors, or NNRTIs.
rilpivirine-associated substitutions with resistance to NNRTIs were susceptible to tenofovir.
This drug is in a class of medications known as non-nucleoside reverse transcriptase inhibitors, or NNRTIs.
other substitutions associated with resistance to rilpivirine and other NNRTIs was susceptible to emtricitabine.